Verrica Pharmaceuticals Inc (VRCA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -76,579 | -60,377 | -37,517 | -20,331 | -66,995 |
| Depreciation Amortization | 1,269 | 1,016 | 674 | 340 | 836 |
| Accounts receivable | 4,200 | 4,401 | -5,777 | -2,753 | -3,860 |
| Accounts payable and accrued liabilities | -568 | -1,499 | -1,330 | 52 | 2,201 |
| Other Working Capital | 2,027 | 6,118 | -4,902 | -2,511 | 9,859 |
| Other Operating Activity | 8,724 | 5,478 | 12,547 | 5,256 | 19,382 |
| Operating Cash Flow | $-60,927 | $-44,863 | $-36,305 | $-19,947 | $-38,577 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -19 | -27 | -11 | N/A | -362 |
| Investing Cash Flow | $-19 | $-27 | $-11 | $N/A | $-362 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 44,105 |
| Debt Repayment | -924 | -1,689 | -1,455 | -665 | -23 |
| Common Stock Issued | 39,792 | 154 | 154 | 4 | 30,307 |
| Other Financing Activity | -1,140 | -163 | 0 | 0 | -176 |
| Financing Cash Flow | $37,728 | $-1,698 | $-1,301 | $-661 | $74,213 |
| Beginning Cash Position | 69,547 | 69,547 | 69,547 | 69,547 | 34,273 |
| End Cash Position | 46,329 | 22,959 | 31,930 | 48,939 | 69,547 |
| Net Cash Flow | $-23,218 | $-46,588 | $-37,617 | $-20,608 | $35,274 |
| Free Cash Flow | |||||
| Operating Cash Flow | -60,927 | -44,863 | -36,305 | -19,947 | -38,577 |
| Capital Expenditure | -27 | -27 | -11 | N/A | -362 |
| Free Cash Flow | -60,954 | -44,890 | -36,316 | -19,947 | -38,939 |